A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
Clinical trial NCT04322292 · COMPLETED
Trial details
- NCT number
- NCT04322292
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-12
- Primary completion
- 2022-09-22
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.